Showing results (61-70 of 133) with videos related to
Sort By:
Pageof 14
Public Health Genomics|April 15, 2010
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based studyP L Mai, L Wideroff, M H Greene, et al.Autoimmunity|January 1, 1996
EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analogW C Buss, J Stepanek, A D Bankhurst, et al.Carcinogenesis|January 1, 1983
Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanomaP J Smith, M H Greene, D Adams, et al.Seminars in Oncology|March 1, 1978
Precursor lesions in familial melanomaM H Greene, R R Reimer, W H Clark, et al.Hematologic Pathology|January 1, 1987
Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agentsJ M Bennett, W C Moloney, M H Greene, et al.Cancer|March 15, 1989
Dysplastic naevi in a population-based surveyK R Cooke, G F Spears, D E Elder, et al.Experimental and Clinical Immunogenetics|January 1, 1988
Immunoglobulin allotypes and familial cutaneous malignant melanoma/dysplastic nevi. A family studyR B Buchmann, S J Bale, M H Greene, et al.American Journal of Obstetrics and Gynecology|June 1, 1984
Prognostic significance of histologic classification and grading of epithelial malignancies of the ovaryG D Malkasian, L J Melton, P C O'Brien, et al.Cancer Treatment Reports|November 1, 1979
Subsequent cancer in patients with Ewing's sarcomaM H Greene, D L Glaubiger, G D Mead, et al.Cancer Research|April 1, 1983
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphomaM H Greene, R C Young, J M Merrill, et al.Pageof 14